a new biotech drug for Crohn's disease called Remicade (infliximab)
July 2001
You'll see a new biotech drug for Crohn's disease called Remicade (infliximab)...from Schering Canada.
It's a monoclonal antibody that neutralizes the activity of tumour necrosis factor...a protein that promotes inflammation.
Remicade reduces symptoms in up to 80% of patients with moderate to severe Crohn's that's resistant to usual treatment.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive